2026. Real-World Safety Profile of Generic Palbociclib in Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer: A Prospective Observational Study in Iraq”. Journal of Cancer Research Updates. 15, 1 (Jun. 2026), 150–155. DOI:https://doi.org/10.30683/1929-2279.2026.15.13.